NCT07511972 2026-04-06
Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
NGM Biopharmaceuticals, Inc
Phase 2 Withdrawn
Clinical Trials
11 trialsNCT07381309 2026-02-02
VVSHIP
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07283367 2025-12-15
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Hansoh BioMedical R&D Company
Phase 1/2 Not yet recruiting
NCT07204574 2025-10-02
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
Chang Gung Memorial Hospital
Phase 1/2 Recruiting
NCT03336658 2024-11-13
ITB
Insel Gruppe AG, University Hospital Bern
Active not recruiting
NCT04984369 2023-08-21
The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05314309 2023-01-11
mtFIT
The Netherlands Cancer Institute
Unknown
NCT05382377 2022-05-19
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT05239650 2022-05-03
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
Shanghai Henlius Biotech
Phase 2 Not yet recruiting
NCT03337776 2021-08-05
Effect of WhatsApp Messenger on Uptake of CRC Screening Study
Chinese University of Hong Kong
Phase NA Withdrawn
NCT03601598 2018-07-26
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
Harbin Medical University
Phase 1/2 Unknown